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NEURAL REGENERATION RESEARCH 
Progesterone effects on the oligodendrocyte linage: all 
roads lead to the progesterone receptor
Introduction
Progesterone is a well-known sex hormone that plays a piv-
otal role in reproductive tissues. However, a new role has 
emerged for the steroid after discovering its potent actions 
away from reproduction in both the central nervous system 
(CNS) and the peripheral nervous system (PNS) (Schum-
acher et al., 2012). Progesterone effects beyond reproduction 
include myelin formation, neuroprotection, anti-inflam-
matory actions, neurogenesis regulation, preservation of 
mitochondrial function and regulation of mood, memory 
and cognition (Brinton, 2013; De Nicola et al., 2018). The 
aim of the present report is to discuss progesterone mecha-
nisms of action involved in myelination, remyelination and 
neuroinflammation. We not only reviewed the preponderant 
role of progesterone receptor (PR) in the mentioned process 
but also described the pro-myelinating actions of its reduced 
derivative tetrahidroprogesterone (THP), a potent agonist of 
the GABAA receptor. Finally, attention is drawn to the fact 
that progesterone actions could be direct on oligodendrocyte 
linage or alternatively indirect through the downregulation 
of the inflammatory process.   
It is important to establish the differences between my-
elination and remyelination. While myelination addresses 
the formation of myelin during development, remyelination 
is related to myelin repair in the adult nervous system. In 
the CNS mature oligodendrocytes in both processes derive 
from the differentiation of oligodendrocyte precursor cells 
(OPC), but adult OPC are indeed distinct from the perinatal 
ones (Fancy et al., 2011). For example, the proliferation rate 
of perinatal OPC is higher than the one found in adult OPC 
(Fancy et al., 2011). Another important difference between 
myelination and remyelination is referred to the signals that 
drive the process. Myelination is mainly driven by axons sig-
nals while remyelination is induced by neuroinflammation 
(for review see Fancy et al., 2011).
Effect of Progesterone on Myelination and 
Remyelination in the Peripheral Nervous 
system
Progesterone pro-myelinating effects were first demonstrated 
20 years ago in the PNS and are summarized in Table 1. In 
this regard, in co-cultures of Schwann cells and dorsal root 
ganglia neurons progesterone accelerates myelination and 
enhances the rate of myelin synthesis (Chan et al., 1998). 
Progesterone also stimulates myelination in the regenerating 
sciatic nerve after a cryolesion (Schumacher et al., 2012) and 
increases both the number of Schwann cells and the g-ratio 
of myelinated fibers during regeneration of the facial nerve 
(Chavez-Delgado et al., 2005).
In the nervous system progesterone can be converted into 
dihidroprogesterone (DHP) by the enzyme 5α-reductase and 
subsequently DHP can be reduced to THP by the enzyme 
3α-hydroxysteroid oxidoreductase (Figure 1) (Schumacher 
et al., 2012; Melcangi and Panzica, 2014). These conversions 
contribute to the pleiotropic mechanisms of progesterone 
since DHP interacts with the PR and THP is a potent posi-
tive modulator of the GABAA receptor (Lambert et al., 2001). 
In the PNS, both Schwann cells and dorsal root ganglia 
neurons express not only the PR and GABAA receptor but 
also the mentioned enzymes, which metabolize progesterone 
into THP (Melcangi et al., 2011). As demonstrated in several 
experimental models, progesterone and its derivatives re-
verse the frequency of myelin morphological abnormalities 
in peripheral nerves during aging (Azcoitia et al., 2003) and 
diabetic disease (Melcangi et al., 2011). 
Progesterone and its reduced metabolites promote the 
synthesis of glycoprotein zero (P0) and the peripheral my-
elin protein 22 (PMP22) by stimulating the expression of key 
transcription factors in the myelination program of Schwann 
cells such as Krox-20, FosB, Sox 10 and Krox 24 (Guennoun 
et al., 2001; Mercier et al., 2001). Progesterone, DHP and 
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Table 1 Effects of progesterone and THP on myelination, remyelination and neuroinflammation.
Steroid Experimental model Studied effects Accions Reference
Prog Cultures of Schwann cells and 
DRG neurons
Myelination in PNS Accelerates myelination and enhances the rate of 
myelin synthesis
Chan et al., 1998
Prog Lesion of facial nerve Remyelination in PNS Increases the number of Schwann cells and the 
g-ratio
Chavez et al., 2005; 
Sclumacher et al., 2012
Prog, DHP, THP Aged mice Remyelination in PNS Reverses morphological myelin abnormalities Azcoitia et al., 2003
Prog, DHP, THP Diabetic mice Remyelination in PNS Reverses morphological myelin abnormalitie Melcangi et al., 2011
Prog, DHP, THP Cultures of Schwann cells and 
adult sciatic nerve
Myelination in PNS Increases P0 and PMP22 Guennoun el al., 2001;
Mercier et al., 2001;
Magnaghi et al., 2007
THP Floating spheres cultures Myelination in CNS Increases OPP proliferation Gago et al., 2004
Prog Cerebellar organotypic 
cultures
Myelination in CNS Increases OPC proliferation, the number of mature 
oligodendrocytes and MBP expression
Ghoumari et al., 2003, 
2005
THP Cerebellar organotypic 
cultures
Myelination in CNS Increases MBP expression Ghoumari et al., 2003, 
2005
Prog Ethidium bromide-induced 
demyelination
Remyelination in CNS Increases the number of remyelinated axons Ibanez et al., 2004
Prog Spinal cord injury Remyelination and 
neuroinflammation  in 
CNS
Increases OPC differentiation, myelin protein 
expression and OPC survival. Decreases the 
number of astrocytes and microglial cells and 
pro-inflammatory cytokines. Promotes anti-
inflammatory microglia
Labombarda et al., 2009, 
2011; Jure et al., 2018
Prog Nestorone Lysolecithin-induced 
demyelination in cerebellar 
organotypic cultures 
Remyelination in CNS Increases MBP expression and OPC migration Hussain et al., 2011
Prog Nestorone Cuprizone-induced 
demyelination 
Remyelination and 
neuroinflammation  in 
CNS
Increases myelin protein expression and the number 
of oligodendrocytes. Decreases the number of 
microglial and astrocytes 
El-Etr et al., 2015
THP Trangenic mice of Alzheimer’s 
disease
Remyelination in CNS Promotes the regeneration of white matter Brinton et al., 2013
Prog THP EAE model Remyelination and 
neuroinflammation in 
CNS
Increases remyelination; Decreases pro-
inflammatory cytokines and microglial cells.
Garay et al., 2012;
Noorbakhsh et al., 2014
Prog Cuprizone-induced 
demyelination
Neuroinflammation  in 
CNS
Promotes the switch from pro-inflamatory to anti-
inflammatory microglia
Aryanpour et al., 2017
Prog: Progesterone; DHP: dihidroprogesterone; THP: tetrahidroprogesterone; DRG: dorsal root ganglia; CNS: central nervous system; PNS: 
peripheral nervous system; EAE: experimental autoimmune encephalomyelitis; OPC: oligodendrocyte precursor cells; MBP: myelin-basic protein; 
OPP: oligodendrocyte pre-progenitors; P0: glycoprotein zero; PMP22: peripheral myelin protein 22. 
Figure 1 Progesterone pleiotropic effects are mediated via the 
progesterone receptor (PR), progesterone membrane receptor 
(mPR), and the membrane-associated protein progesterone 
receptor-membrane component-1 (PGRMC1). 
Progesterone can be reduced to dihidroprogesterone (DHP) by the 
enzyme 5α-reductase (5α-red). DHP can also activate PR. DHP is sub-
sequently converted into tetrahidroprogesterone (THP) by the enzyme 
3α-hydroxysteroid oxidoreductase (3α-HSD). THP activates the GAB-
AA receptor.
THP increase Po and PMP22 expression in the adult sciatic 
nerve and in Schwann cell cultures (Melcangi et al., 2011) 
using different mechanisms of action (Magnaghi et al., 
2001). On the one hand, progesterone, DHP and THP en-
hance mRNA levels of P0 involving PR as the potent PR-an-
tagonist RU-486 abolishes P0 up-regulation (Magnaghi et al., 
2001). Since the enzyme 3α-hydroxysteroid oxidoreductase 
is bi-directional (Rupprecht et al., 1996) the action of THP 
(which does not bind PR) may be due to its retro-conversion 
into DHP. On the other hand, neither progesterone nor DHP 
increase the mRNA levels of PMP22 (Magnaghi et al., 2001). 
Only THP stimulating the GABAA receptor is able to modify 
PMP22 expression. Altogether, these results indicate that 
both PR and GABAA receptor are involved in the regulation 
of PNS myelination.
Involvement of Progesterone in 
Developmental Myelination in the Central 
Nervous system
Progesterone effects on myelin formation in the PNS are 
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also described in the CNS. Table 1 shows progesterone 
actions on the CNS. Schumacher’s group was the first to de-
scribe progesterone actions on developmental myelination 
in the oligodendroglial linage (Gago et al., 2001, 2004) and 
organotypic cultures (Ghoumari et al., 2003, 2005). In this 
regard, progesterone and THP are synthetized by oligoden-
drocyte pre-progenitors (OPP) during their differentiation 
into mature oligodendrocytes and increase their prolifera-
tion in cultures obtained from floating spheres (Gago et al., 
2001; 2004). Progesterone increases the proliferation of OPP 
through its conversion to THP, while THP enhances their 
proliferation activating the GABAA receptor (Gago et al., 
2004). These progenitors release GABA, which is involved 
in their proliferation, generating an autocrine mechanism 
of propagation. In this respect, THP and GABA in neural 
progenitor cells depolarize the plasma membrane and open 
the voltage-dependent L-type Ca2+ channel. Calcium influx 
leads to a downstream signaling pathway via Ca2+-depen-
dent kinase which activates the cyclic AMP-responsive ele-
ment-binding protein 1 and genes that regulate the cell cycle 
(Wang et al., 2005). 
In cerebellar organotypic cultures, while progesterone in-
creases OPC proliferation, the number of mature oligoden-
drocytes and myelin-basic protein (MBP) expression, THP 
only enhances MBP synthesis (Ghoumari et al., 2003; 2005). 
In OPC, which are more differentiated than OPP, proges-
terone and THP enhance MBP levels involving mainly PR 
and to a lesser extent the GABAA receptor (Ghoumari et al., 
2003). PR plays a key role in OPC as no progesterone pro-
myelinating effects have been observed in PR knockout mice 
(Ghoumari et al., 2003; 2005). These results suggest that 
THP modulates OPP proliferation but as cells become more 
and more differentiated progesterone may drive this process 
via PR.
Effect of Progesterone on Remyelination in the 
Central Nervous system
The prolonged administration of progesterone enhances 
the number of remyelinated axons in a model of toxin-in-
duced demyelination in the brain of aging rats (Ibanez et al., 
2004). In the mentioned model, the rate of remyelination 
is age-dependent and the process is efficient only in young 
rats. In this scenario, progesterone does not modify the re-
myelination process of young animals but exerts pro-myelin-
ating effects on aged rats, where remyelination occurs with 
sub-optimal efficiency (Ibanez et al., 2004).
De Nicola’s group was the first to demonstrate that proges-
terone indeed differentiates proliferating OPC into mature 
oligodendrocyte after spinal cord injury (SCI) (Labombarda 
et al., 2006, 2009; Jure et al., 2019). Prolonged progesterone 
administration during 21 days after SCI increases the num-
ber of mature oligodendrocytes and enhances the expression 
of both mRNA and protein of MBP and proteolipid protein 
(Labombarda et al., 2009). During the acute phase after SCI, 
progesterone treatment enhances OPC survival and stimu-
lates mitotic OPC to differentiate into mature oligodendro-
cytes after 3 weeks of treatment (Labombarda et al., 2009, 
2015). 
The differentiation program is a regulated process which 
involves the finely-tuned interplay of transcription factors 
and epigenetic modifiers (Huang et al., 2013). This program 
involves the synchronization of transcriptional inhibitors 
downregulation  with the upregulation of transcriptional 
activators (Liu and Casaccia, 2010). The downregulation of 
the transcriptional inhibitors opens a window of opportunity 
for the activators to enhance and drive remyelination. It has 
been recently published that after SCI both the transcrip-
tional inhibitors of the differentiation program and the tran-
scriptional activators are down-regulated (Jure et al., 2019). 
Thus OPC missed the window of opportunity to differentiate 
after SCI. However, after progesterone treatment, the num-
ber of OPC which express the transcriptional activators of 
the differentiation program are up-regulated and the process 
is stimulated (Jure et al., 2019). Specifically, the expression of 
mRNA levels of the key activators of the differentiation pro-
gram such as Olig2, Nkx2.2, Sox10 and Mash1 is enhanced 
after progesterone administration (Jure et al., 2019). The 
mentioned transcription factors are well-known players in 
OPC commitment to mature oligodendrocytes (Huang et al., 
2013; Mitew et al., 2014). 
Additionally, a recent report using MRI technology has 
demonstrated that progesterone reduces secondary damage 
and preserves white matter volume after spinal cord con-
tusion (Garcia-Ovejero et al., 2014). They have shown that 
progesterone treatment increases the number of mature oli-
godendrocytes. After the CatWalk gait analysis, they found 
that the steroid improves locomotor outcome after SCI (Gar-
cia-Ovejero et al., 2014).  
Several publications have supported these results showing 
progesterone remyelintation properties. Progesterone and 
nestorone (a potent PR agonist) increase MBP expression 
after lysolecithin-induced demyelination in cerebellar slices 
(Hussain et al., 2011) and enhance remyelination after cupri-
zone treatment in corpus callosum and cerebral cortex (El-
Etr et al., 2015). Remyelinating progesterone and nestorone 
actions are mediated by PR since the use of PRKO trans-
genic mice inhibits progesterone effect in the mentioned 
models (Hussain et al., 2011; El-Etr et al., 2015). Notably, 
in cerebellar organotypic cultures Nestorone enhances not 
only the maturation of OPC but also the migration of these 
progenitors towards demyelinating axons after lysolecithin 
application (Hussain et al., 2011). On the contrary, medroxy-
progesterone acetate (MPA) has no effect neither on MBP 
immunoreactivity nor on the replenishment of oligoden-
drocytes in the mentioned demyelinated cerebellar culture 
(Hussain et al., 2011). It is known that glucocorticoids are 
not involved in the remyelination of cerebellar slices (Hussain 
et al., 2011). As a consequence, MPA remyelinating failure 
may be due to binding not only to PR but also to GR.
Finally, with regard to the effects of THP on remyelination 
in the CNS, Brinton (2013) has demonstrated that the steroid 
enhances myelin protein expression and promotes regener-
ation of white matter in a transgenic mice model of Alzhei-
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mer’s disease. On the other hand, in the experimental auto-
immune encephalomyelitis (EAE) model of multiple sclerosis 
(MS), progesterone and THP attenuate neurological deficits 
and increase remyelination (Yu et al., 2010; Garay et al., 
2012). An outstanding study reported a significant decrease 
in the rate of relapses in MS patients during pregnancy and 
a significant increase during the first three months post-par-
tum by comparison to the relapse rate observed during the 
year prior to pregnancy (Vukusic et al., 2009). Based on these 
results, a clinical trial began in 2009 (POPART´MUS – Refer-
ence number NTC00127075) using a synthetic progestin (no-
megestrol acetate) to prevent post-partum relapses in women 
with MS. The POPART´MUS study is still ongoing. 
Possible Mechanisms for the Pro-Myelinating 
Effect of Progesterone
The precise mechanism in myelin formation in the CNS 
is controversial. As already mentioned PR is involved in 
developmental myelination (Ghoumari et al., 2003, 2005) 
and remyelination (Hussain et al., 2011; El-Etr et al., 2015; 
Labombarda et al., 2015). However, it is currently unknown 
whether progesterone stimulates OPC differentiation direct-
ly and/or indirectly by the regulation of astrocytes, neurons 
and microglial cells. Indeed, PR has been detected in the spi-
nal cord not only in neurons but also in glial cells (Labom-
barda et al., 2000). 
Regarding direct progesterone actions on the oligodendro-
cyte linage, PR expression in oligodendrocytes remains to 
be clarified. Several reports have determined the expression 
of PR in oligodendrocyte cultures and in the white matter of 
the spinal cord by immunohistochemistry (Jung-Testas et al., 
1991; Labombarda et al., 2000). However, these publications 
do not demonstrate exactly in which type of cell PR is ex-
pressed, since a double labeling experiment with an antibody 
against PR and antibody against a cell-specific marker of 
oligodendrocyte linage has not been  performed (Jung-Testas 
et al., 1991; Labombarda et al., 2000). Concerning progester-
one effects in vitro, the steroid is synthetized by OPC during 
the differentiation program in neurosphere-derived cultures 
(Gago et al., 2001) and increases the number of MBP-pos-
itive oligodendrocytes in mixed glial cell cultures (Schum-
acher et al., 2012). However, the intervention of other glial 
cells should not be ruled out since both cultures are not 
extremely pure and contain a small percentage of astrocytes 
(Gago et al., 2001). Experiments showing PR expression in 
OPC should be performed in the future since there are no 
reports in the literature that demonstrate it convincingly.  
Astroglial and microglial cells regulate adult OPC differen-
tiation in several pathological situations. In this regard, after 
lesions to the spinal cord, astrocytes and microglia cells react 
and produce proinflammatory mediators, oxygen free rad-
icals and neurotoxic levels of nitric oxide (Sofroniew, 2009; 
Zhou et al., 2014). These proinflammatory mediators pro-
duce a feed-forward mechanism that propagates secondary 
injury and inflammation. Neuroinflammation contributes to 
white matter demyelination, oligodendrocyte loss and lack 
of OPC differentiation reported in SCI (Bracchi-Ricard et 
al., 2013). In mixed glial cultures, activated microglial cells 
release TNF-α which induces the apoptosis of OPC via the 
TNFR1 expressed in these cells. The same authors describe 
that astrocytes participate in promoting TNF-α toxicity to 
OPC in a contact-dependent manner (Kim et al., 2011).   
Recent evidence has shown that progesterone decreases the 
number of astrocytes and microglial cells after SCI (Labom-
barda et al., 2011, 2015). Moreover, the steroid down-regu-
lates the mRNA expression of interleukin-1β, tumor necrosis 
factor α, interleukin-6, inducible nitric oxide synthase, cy-
clooxygenase-2 (Labombarda et al., 2015) and increases the 
expression of transforming growth factor β, an anti-inflam-
matory and potent OPC differentiating factor (Palazuelos 
et al., 2014; Jure et al., 2019). Noteworthy, progesterone in-
creases the number of transforming growth factorβ-express-
ing astrocytes and microglial cells (Jure et al., 2019). Based 
on the fact that anti-inflammatory microglial cells drive 
OPC differentiation (Miron and Franklin, 2014) the change 
of microglia phenotype caused by progesterone could create 
a pro-differentiating environment for OPC. These results are 
in agreement with another report which indicates that pro-
gesterone therapy induces a switch in microglia phenotype 
from pro-inflammatory to anti-inflammatory and suppresses 
NLRP3 inflammasome in cuprizone-induced demyelination 
mice (Aryanpour et al., 2017). These immunomodulatory ef-
fects evoke progesterone actions during pregnancy, in which 
a change occurs from the Th1 pro-inflammatory to a Th2 
anti-inflammatory response (De Leon-Nava et al., 2009; Sze-
keres-Bartho et al., 2009). Other publications have supported 
these findings showing that progesterone has anti-inflam-
matory effects along with the aforementioned remyelinating 
actions in different animal models such as EAE (Yates et al., 
2010; Garay et al., 2012) and chemical-induced demyelin-
ation ones (El-Etr et al., 2015). Table 1 compiles the action 
of progesterone on neuroinflammation.  
In accordance with the promyelinating actions, progester-
one anti-inflammatory effects also depend on PR. It has been 
recently published, that PR via NF-κB downregulates the 
expression of interleukin-1β, tumor necrosis factorα and in-
terleukin-6 mRNA after SCI (Labombarda et al., 2015). The 
modulation of astrocytes and microglial cells also requires 
PR, since their number remains elevated after progesterone 
treatment in spinal cord injured PRKO mice (Labombarda 
et al., 2015). Interestingly, PR is not expressed in surveillance 
microglial cells (Sierra et al., 2008). Thus, progesterone ef-
fects on microglial cells might be due to astrocyte and neu-
ron modulation. Since progesterone stimulates growth factor 
production via PR-signaling in astrocytes, these cells become 
an interesting target of progesterone (Lacroix-Fralish et al., 
2006; Chesik and De Keyser, 2010). On the other hand, neu-
rons could also be involved in progesterone actions because 
they express PR (Labombarda et al., 2000). However, after 
SCI the level of PR expression is downregulated in motoneu-
rons (Labombarda et al., 2003). One more interesting possi-
bility is that microglial cells up-regulate PR expression after 
CNS injury or other demyelinating diseases. This alternative 
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should be explored in future experiments. Since peripheral 
macrophages express PR and progesterone modulates their 
function via a PR-dependent mechanism (Khan et al., 2005; 
Jones et al., 2008) another possibility arises. Progesterone 
could exert anti-inflammatory actions by inhibiting the in-
filtrated macrophages which invade the tissue after SCI, EAE 
induction and chemical-demyelination (Garay et al., 2012; 
El-Etr et al., 2015; Labombarda et al., 2015). In the case of ly-
solecithin-induced demyelination in cerebellar organotypic 
cultures, the perivascular macrophages could invade the tis-
sue and mediate progesterone actions (Hussain et al., 2011).
Based on experimental evidence, progesterone effects on 
neuroinflammation and oligodendrocyte linage involve a 
PR-dependent mechanism (Ghoumari et al., 2003, 2005; 
Hussain et al., 2011; El-Etr et al., 2015; Labombarda et al., 
2015). However, the involvement of other progesterone 
signaling mechanisms cannot be totally excluded. In fact, 
progesterone interacts with several G-couple- membrane 
receptors and the PR membrane component 1 (Figure 1). In 
addition, as already mentioned, progesterone is reduced to 
THP (GABAA modulator), which enhances the proliferation 
of oligodendrocyte pre-progenitors (Gago et al., 2004) and 
MBP synthesis (Ghoumari et al., 2003) (Figure 1).         
Progesterone could exert myelinating and remyelinating 
effects by two possible mechanisms. On the one hand, it acts 
directly on the oligodendrocyte linage (if PR expression is 
definitely confirmed). Further experiments in vitro with ex-
tremely pure OPC cultures are needed to confirm this possi-
bility. On the other hand, it acts indirectly via the inhibition 
of neuroinflammation by modulation of astroctyes, neurons 
and probably infiltrated macrophages.   
Conclusion
Progesterone and THP seem to be good candidates to treat 
demyelinating diseases as both steroids enhance remyelin-
ation. Whether progesterone pro-myelinating effects are 
acting directly on oligodendrocyte linage or only mediated 
by the regulation of the neuroinflammatory process still re-
mains unclear. Concerning the mechanism of action, how 
it is possible that progesterone antinflammatory actions are 
mediated by PR when microglial cells do not express this 
receptor. On the other hand, OPC and challenged microglial 
express the mPRα receptor (Labombarda et al., 2010). This 
non-canonical PR may also play a role in myelinating cells 
and neuroinflammation. However, how PR and the GAB-
AA receptor interaction contribute to OPC differentiation 
and myelin synthesis is still unknown. The downstream 
pathways of both receptors might cross talk to each other 
and regulate oligodendrogenesis. THP via GABAA receptor 
could contribute to the early differentiation of OPP, when 
GABAA receptor activates Ca
2+-dependent kinases (Brinton, 
2013), while progesterone via PR might enhance late dif-
ferentiation. Further experiments should be performed to 
elucidate these assumptions. Lastly, it needs to be established 
if progesterone mechanisms of action in myelination are 
different from those involved in remyelination? Elucidation 
of multiple progesterone mechanisms remains an exciting 
challenge. During the last few years more groups have stud-
ied the effects of progesterone on myelination, remyelination 
and neuroinflammation. In the future new data related to 
progesterone effects on oligodendrogenesis is expected, de-
signing novel therapeutic strategies based on progesterone 
pro-myelinating actions for treating demyelinating diseases. 
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